Skip to content
Navigate to the Corvia Medical website home page Corvia Medical Navigate to the Corvia Medical website home page
  • Find a Center
  • Safety Info
  • Newsroom
    • Press Releases
    • Media Resources
    • In the News
  • Contact
  • International
    • US
  • Corvia Atrial Shunt System
  • Patients
  • Healthcare Professionals
    • Dynamic Decompression
    • Clinical Evidence Summary
    • Clinical Program
    • RESPONDER-HF
    • Patient Identification & Referral
    • Reimbursement
    • Presentations, Abstracts, Publications
  • About Us
    • Leadership
    • Board of Directors
    • Investors
    • Patents
  • Find a Center
  • Safety Info
  • Newsroom
    • Press Releases
    • Media Resources
    • In the News
  • Contact
  • US
  • Corvia Atrial Shunt System
  • Patients
    • Learn About Heart Failure
    • Learn About Atrial Shunting
    • Heart Failure Symptom Check
    • Find A Doctor
  • Healthcare Professionals
    • Dynamic Decompression
    • Clinical Evidence Summary
    • Clinical Program
    • RESPONDER-HF
    • Patient Identification & Referral
    • Corvia Atrial Shunt Responders
    • Reimbursement
    • Presentations, Abstracts, Publications
  • About Us
    • Leadership
    • Board of Directors
    • Investors
    • Patents

Category: Press Releases

DC Devices Closes $34m Series D Financing to Complete Clinical Evaluation of the First Transcatheter Device to Treat Diastolic Heart Failure

DC Devices Closes $34m Series D Financing to Complete Clinical Evaluation of the First Transcatheter Device to Treat Diastolic Heart Failure

Read More

DC Devices Secures $9 Million Financing; Lumira Capital Joins Syndicate of Leading Investors

DC Devices Secures $9 Million Financing; Lumira Capital Joins Syndicate of Leading Investors

Read More

Posts navigation

Newer posts

Corvia Medical, Inc.

One Highwood Drive, Suite 300
Tewksbury, MA 01876
USA

+1 978-654-6123
info@corviamedical.com

The Corvia Atrial Shunt System (IASD®)

is indicated for the improvement in quality of life and reduction of heart failure related symptoms and events in patients with heart failure with preserved (HFpEF) or mid-range ejection fraction (HFmrEF) with elevated left atrial pressures, who remain symptomatic despite standard guideline directed medical therapy.

© 2025 Corvia Medical. All rights reserved. Privacy Policy

Corvia and IASD are registered trademarks of Corvia Medical, Inc.

CAUTION–Investigational Device. Limited by United States Law to Investigational Use.

I understand

Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
Preferences
{title} {title} {title}